Voting Rights Announcements | 16 December 2014 17:09


RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÖN-KLINIKUM AG 

16.12.2014 17:09

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Notification according to section 26 para. 1 WpHG 

Prof. Dr. h.c. Ludwig Georg Braun, Ilona Braun, Martin Lüdicke, B. Braun
Holding GmbH & Co. KG, die BraHo Verwaltungsgesellschaft mbH, Ludwig G.
Braun GmbH & Co. KG and B. Braun Melsungen Aktiengesellschaft (the
aforementioned persons collectively the 'Notifying Persons') have informed
RHÖN-KLINIKUM AG on November 21, 2014 that their voting interest in
RHÖN-KLINIKUM Aktiengesellschaft has crossed the threshold of 10% and 15%
on November 20, 2014.

With respect to the objectives pursued with the acquisition of the voting
rights, the Notifying Persons have informed us on December 15, 2014,
pursuant to Section 27a para 1 sentence and 3 of the German Securities
Trading Act (Wertpapierhandelsgesetz - WpHG) of the following:

 1. The investment is used to implement strategic objectives. 

 2. Within the next twelve months, the Notifying Persons intend - within
    their plan to sustainably secure their minority shareholding in
    RHÖN-KLINKUM Aktiengesellschaft - to obtain further voting rights by
    acquisition or any other way.

 3. The Notifying Persons continue to aim at a representation on the
    supervisory board of RHÖN-KLINIKUM Aktiengesellschaft relative to the
    significance of their shareholding in RHÖN-KLINIKUM Aktiengesellschaft.
    Beyond that, the Notifying Persons do not intend to influence the
    composition of the administration, management or supervisory board of
    RHÖN-KLINIKUM Aktiengesellschaft

 4. The Notifying Persons do not intend to change the capital structure of
    RHÖN-KLINIKUM Aktiengesellschaft, especially with regards to the ratio
    of internal/outside financing and the dividend policy.

With respect to the origin of the used funds, the Notifying Persons notify
according to section 27a para 1 sentence 4 of the German Securities Trading
Act that the used funds are partly own funds and predominantly external
funds in order to finance the purchase of the voting rights. However, the
thresholds of 10% and 15% were crossed in consequence of the redemption of
shares by RHÖN-KLINIKUM Aktiengesellschaft on November 20, 2014, so that
the Notifying Persons did not have to spend additional funds for the
crossing of these concrete thresholds.

 

Bad Neustadt a.d. Saale, 16 December 2014

The Board of Management

___________________________________________________________________________

Dr. Kai G. Klinger
SVP - Investor Relations, Corporate Finance and M&A
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



16.12.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------